Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • Diagnostic criteria for glucose disorders in HIV-infected patients on ART have been described (Table 9)[ADA 2013a; ADA 2013b]
  • Fasting, random, or oral glucose tolerance testing may be used in screening patients
  • Fasting blood glucose should be undertaken in all HIV-infected patients at entry to care, every 6-12 months thereafter, and before ART initiation

    Action required

    Keywords: Diabetes, Insulin Resistance, Treatment Complications

    ©2020 Clinical Care Options, LLC. All Rights Reserved.

    The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.